February 2026
1. WANG WJ, Wang SA, Al-Atrash G, Fang H, et al
   T-cell mixed chimerism after allogeneic hematopoietic stem cell transplantation does not correlate with relapse in patients with acute myeloid leukemia.
   Leuk Res. 2026;162:108185.
   

   >> Share

   
   
2. HOU HA, Getta B, Ahn JS, Elsouda D, et al
   Outcomes of patients with R/R FLT3(mut+) AML treated with maintenance gilteritinib therapy after hematopoietic stem cell transplantation.
   Leuk Res. 2026;162:108186.
   

   >> Share

   
   January 2026
3. KHAN A, Gajendra S, Singh VK, Thakral D, et al
   Single cell transcriptomics derived combinatorial markers distinguished leukemic stem cells from hematopoietic stem cells in acute myeloid leukemia.
   Leuk Res. 2026;161:108170.
   

   >> Share

   
   December 2025
4. RONNACKER J, Urbahn MA, Reicherts C, Kolloch L, et al
   Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemia.
   Leuk Res. 2025;160:108153.
   

   >> Share

   
   
5. BHATIA I, Patel S, Pearson L, Parthiban K, et al
   Outcomes of adults older than 70 years of age undergoing allogeneic stem cell transplantation.
   Leuk Res. 2025;160:108145.
   

   >> Share

   
   November 2025
6. KOJO K, Sadato D, Toya T, Oboki K, et al
   NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation.
   Leuk Res. 2025;160:108135.
   

   >> Share

   
   
7. ITONAGA H, Miyazaki Y, Fujioka M, Kurosawa S, et al
   Differential impact of graft-versus-host disease on post-transplant outcomes of chronic myelomonocytic leukemia according to transplant procedures.
   Leuk Res. 2025;159:108134.
   

   >> Share

   
   October 2025
8. LI J, Li F, Zhang M, Wu Y, et al
   Exosomal miR-140-3p produced by bone marrow stromal cells affects acute myeloid leukemia cell growth and apoptosis by targeting SUZ12.
   Leuk Res. 2025;159:108122.
   

   >> Share

   
   September 2025
9. YAP S, Kelly A, Goldsbury D, Weber MF, et al
   Health system costs and autologous stem cell transplant receipt for participants with multiple myeloma in the Australian 45 and Up Study.
   Leuk Res. 2025;158:108100.
   

   >> Share

   
   August 2025
10. YANG Q, Ding Z, Liu Y, Chen S, et al
    Effect of sorafenib on prognosis in patients with low-allelic-ratio FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
    Leuk Res. 2025;157:108088.
    

    >> Share

    
    June 2025
11. AMIN MK, Khan MA, Khan FH, Zakir A, et al
    Impact of FLT3 inhibitors on the outcomes of FLT3-ITD mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant: A systematic review and meta-analysis.
    Leuk Res. 2025;155:107724.
    

    >> Share

    
    May 2025
12. LI X, Cai Y, Yang J, Huang C, et al
    Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation.
    Leuk Res. 2025;154:107721.
    

    >> Share

    
    April 2025
13. AUBREY BJ, Blonquist T, McMasters M, Hobbs G, et al
    A phase I clinical trial of lenalidomide combined with bortezomib for acute myeloid leukemia or myelodysplastic syndrome relapsing after allogeneic stem cell transplantation.
    Leuk Res. 2025;153:107693.
    

    >> Share

    
    January 2025
14. CHO H, Kim J, Park Y, Lee BH, et al
    The presence of clonal isotype switch after autologous stem cell transplantation as a prognostic biomarker for long-term survival in patients with multiple myeloma.
    Leuk Res. 2025;149:107641.
    

    >> Share

    
    December 2024
15. SHAHZAD M, Iqbal Q, Amin MK, Irfan S, et al
    Outcomes of hematopoietic stem cell transplantation in primary plasma cell leukemia: A systematic review and meta-analysis.
    Leuk Res. 2024;148:107640.
    

    >> Share

    
    November 2024
16. ROUZBAHANI M, Mousavi SA, Hajianfar G, Ghanaati A, et al
    Predictive modeling of outcomes in acute leukemia patients undergoing allogeneic hematopoietic stem cell transplantation using machine learning techniques.
    Leuk Res. 2024;148:107619.
    

    >> Share

    
    
17. LUCCHINI G, Cozma E, Jackson A, Gilmour K, et al
    COVID-19 infection in adult and paediatric recipients of allogeneic stem cell transplantation: The UK experience.
    Leuk Res. 2024;147:107618.
    

    >> Share

    
    
18. HUANG X, Wu X, Wang S, Ren Y, et al
    Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single center.
    Leuk Res. 2024;147:107617.
    

    >> Share

    
    October 2024
19. WAIS V, Gantner A, Strauss K, Neagoie A, et al
    Treatment of steroid-refractory acute/chronic graft versus host disease: A single-center real-world experience of ruxolitinib in combination with extracorporeal photopheresis in a high-risk population.
    Leuk Res. 2024;147:107611.
    

    >> Share

    
    August 2024
20. SHIMIZU H, Kato J, Tanoue S, Kimura SI, et al
    Allogeneic stem cell transplant with TBI-based myeloablative conditioning in adolescents and young adults with Philadelphia chromosome-negative ALL treated with pediatric protocols.
    Leuk Res. 2024;144:107562.
    

    >> Share

    
    April 2024
21. INDRAN T, Das T, Muirhead J, O'Brien M, et al
    Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34(+) and CD3(+) donor chim
    Leuk Res. 2024;142:107504.
    

    >> Share

    
    
22. ASHOURI K, Ginosyan AA, Chu M, Hom B, et al
    Donor matters: Donor selection impact on hematopoietic stem cell transplantation outcomes in Hispanic patients with B-cell acute lymphocytic leukemia: Insights from a myeloablative HSCT study.
    Leuk Res. 2024;141:107501.
    

    >> Share

    
    March 2024
23. BRUNETTI M, Iasenza IA, Jenner AL, Raynal NJ, et al
    Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia.
    Leuk Res. 2024;140:107485.
    

    >> Share

    
    
24. KILIC GUNES E, Yigit Kaya S, Yaman F, Yeniay MK, et al
    Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience.
    Leuk Res. 2024;140:107484.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share